Artificial Pancreas Device System (APDS) Market: Size, Share, Trends, Demand, Key Players, Y-O-Y Growth Analysis, Drivers, Restraints, Market Opportunities, USP, SWOT Analysis

Global Artificial Pancreas Device System (APDS) Market Outlook 2017-2025

Market Overview

Closed-loop artificial pancreas device (APD) systems are externally wearable medical devices that are being developed to assist patients with type 1 diabetes to control their blood glucose levels in a more automated way. Occasionally an artificial pancreas device system is also denoted as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control. Further, rapidly growing diabetic patient population across the globe has provided the huge market space for the APD systems growth. In 2012, 29.1 million Americans, or 9.3 percent of the population, had diabetes, of whom approximately 1.25 million had T1DM, according to Centers for Disease Control and Prevention [CDC], 2015. Moreover, trends growth of home healthcare sector along with increasing demand for insulin self-management by diabetic patients will fuel artificial pancreas device system market size.

Numerous organizations and new startups are also taking initiatives to develop technologically advanced artificial pancreas device system. Further, governments and regulatory authorities are also approving various advanced APD systems and innovative products which are significantly growing the reach of the companies in various markets. For instance, the FDA is joining forces with diabetes patient groups, diabetes care providers, medical device manufactures, researchers, and academic investigators to nurture innovation by clarifying agency prospects for clinical studies and product approvals.

However, artificial pancreas systems aren’t an alternative for most diabetics. R&D today focuses on treating type 1 diabetics, whose pancreas produces little or no insulin. Type 1 patients make up no more than 10% of all diabetics around the world.

Goldstein Research analyst forecast global artificial pancreas device system market is likely to thrive with the emergence of new technologies and surge in digitalization of medical procedures and demand for analytic solutions. Further, the artificial pancreas device system market is expected to expand at a CAGR of 20.4% over the forecast period and the major growth regions are likely to be the Europe and Asia Pacific.

Global Artificial Pancreas Device System Market Segmentation

By Device Type

• CTR (Control to Range) Systems
• CTT (Control to Target) Systems
• Threshold suspended device system

Based on type of device type, the o Threshold suspended device system segment is anticipated to account for the largest share of the APD system market. Further, CTR and CTT systems market is probable to observe significant growth over the forecast period owing to their capability to manage hypoglycemic as well as hyperglycemic glucose incidences.

By Geography

• North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Artificial Pancreas Device System Market
• Europe (UK, France, Italy, Germany, Spain, Sweden, Russia, Netherlands, Norway and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Artificial Pancreas Device System Market
• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Artificial Pancreas Device System Market
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Artificial Pancreas Device System Market
• Asia Pacific (China, Japan, India, Singapore, South Korea, Australia and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Artificial Pancreas Device System Market

Based on geography, North America is expected to dominate the market followed by Europe during the forecast period. Dominance of North America is majorly attributed to the advanced healthcare infrastructure and dominance in global healthcare IT industry. Moreover, US will maintain its dominance in North America over the forecast period. Existence of organizations such as JDRF that delivers funding for type 1 diabetes research activities and treatment along with rapid adoption of latest technology in the U.S. will drive the U.S. artificial pancreas device systems market over the forecast period.

Covered In This Global Artificial Pancreas Device System Market Report                                                                                                                  

The report covers the present ground scenario and the future growth prospects of the APD systems for 2017-2025 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players in all major regions. Global Artificial Pancreas Device System Market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

Global Artificial Pancreas Device System Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Artificial Pancreas Device System Market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Global Artificial Pancreas Device System Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Our Global Artificial Pancreas Device System Market Report comprises of the following companies as the key players: Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key Questions Answered In This Global Artificial Pancreas Device System Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Artificial Pancreas Device System Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Artificial Pancreas Device System Market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects